Comorbidities in patients with Unverricht–Lundborg disease (EPM1)
Background Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these. Aims of the Study To investigate the frequency of comorbidities in EPM1. Methods Comorbidity data of a previously describ...
Gespeichert in:
Veröffentlicht in: | Acta neurologica Scandinavica 2022-11, Vol.146 (5), p.690-693 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 693 |
---|---|
container_issue | 5 |
container_start_page | 690 |
container_title | Acta neurologica Scandinavica |
container_volume | 146 |
creator | Sipilä, Jussi O. T. Kälviäinen, Reetta |
description | Background
Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these.
Aims of the Study
To investigate the frequency of comorbidities in EPM1.
Methods
Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals.
Results
Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population.
Conclusions
Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs. |
doi_str_mv | 10.1111/ane.13706 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9826374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2714065179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</originalsourceid><addsrcrecordid>eNp1kU1O3DAYhi3Uqgy0Cy6AInUDi8Dnn9jOBgkNA1QaaBdlbTmOwxhl4qmdgNhxBy7AWTgKJ8EwgCgS3tiWHz16P78IbWDYwWnt6s7uYCqAr6AR5gA5MGBf0AgAcM4pZqtoLcaLdCOCsW9olXIohaTlCB2M_dyHytWudzZmrssWOp26PmZXrp9lZ92lDcGZWf9wczsdurry4TyrXbQ62vu7rcmfE7z9HX1tdBvtj5d9HZ0dTv6Oj_Pp76Nf4_1pbmghec5KTkrJqkaSgtSGaCsb4KymBgzBBHhT6IJVFAoiLOMVEMkrYTQlxhamNHQd7S29i6Ga29qkmEG3ahHcXIdr5bVT_790bqbO_aUqJeFUsCTYehEE_2-wsVdzF41t2_SDfoiKCMyAF1iUCf35Ab3wQ-jSeIkijDEBUiZqe0mZ4GMMtnkLg0E9daOSWT13k9jN9-nfyNcyErC7BK5ca68_N6n908lS-QgeDJkn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724447088</pqid></control><display><type>article</type><title>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sipilä, Jussi O. T. ; Kälviäinen, Reetta</creator><creatorcontrib>Sipilä, Jussi O. T. ; Kälviäinen, Reetta</creatorcontrib><description>Background
Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these.
Aims of the Study
To investigate the frequency of comorbidities in EPM1.
Methods
Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals.
Results
Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population.
Conclusions
Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.</description><identifier>ISSN: 0001-6314</identifier><identifier>EISSN: 1600-0404</identifier><identifier>DOI: 10.1111/ane.13706</identifier><identifier>PMID: 36097839</identifier><language>eng</language><publisher>Denmark: Hindawi Limited</publisher><subject>Ankle ; Clinical ; clinical neurology ; Cohort Studies ; Comorbidity ; Diabetes mellitus ; Diagnosis ; epileptic syndromes ; Finland - epidemiology ; hereditary disorders ; Humans ; Male ; Metabolic disorders ; Patients ; rare epilepsies ; Trauma ; Unverricht-Lundborg Syndrome - pathology</subject><ispartof>Acta neurologica Scandinavica, 2022-11, Vol.146 (5), p.690-693</ispartof><rights>2022 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2022 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</citedby><cites>FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fane.13706$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fane.13706$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36097839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sipilä, Jussi O. T.</creatorcontrib><creatorcontrib>Kälviäinen, Reetta</creatorcontrib><title>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</title><title>Acta neurologica Scandinavica</title><addtitle>Acta Neurol Scand</addtitle><description>Background
Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these.
Aims of the Study
To investigate the frequency of comorbidities in EPM1.
Methods
Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals.
Results
Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population.
Conclusions
Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.</description><subject>Ankle</subject><subject>Clinical</subject><subject>clinical neurology</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>epileptic syndromes</subject><subject>Finland - epidemiology</subject><subject>hereditary disorders</subject><subject>Humans</subject><subject>Male</subject><subject>Metabolic disorders</subject><subject>Patients</subject><subject>rare epilepsies</subject><subject>Trauma</subject><subject>Unverricht-Lundborg Syndrome - pathology</subject><issn>0001-6314</issn><issn>1600-0404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kU1O3DAYhi3Uqgy0Cy6AInUDi8Dnn9jOBgkNA1QaaBdlbTmOwxhl4qmdgNhxBy7AWTgKJ8EwgCgS3tiWHz16P78IbWDYwWnt6s7uYCqAr6AR5gA5MGBf0AgAcM4pZqtoLcaLdCOCsW9olXIohaTlCB2M_dyHytWudzZmrssWOp26PmZXrp9lZ92lDcGZWf9wczsdurry4TyrXbQ62vu7rcmfE7z9HX1tdBvtj5d9HZ0dTv6Oj_Pp76Nf4_1pbmghec5KTkrJqkaSgtSGaCsb4KymBgzBBHhT6IJVFAoiLOMVEMkrYTQlxhamNHQd7S29i6Ga29qkmEG3ahHcXIdr5bVT_790bqbO_aUqJeFUsCTYehEE_2-wsVdzF41t2_SDfoiKCMyAF1iUCf35Ab3wQ-jSeIkijDEBUiZqe0mZ4GMMtnkLg0E9daOSWT13k9jN9-nfyNcyErC7BK5ca68_N6n908lS-QgeDJkn</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Sipilä, Jussi O. T.</creator><creator>Kälviäinen, Reetta</creator><general>Hindawi Limited</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202211</creationdate><title>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</title><author>Sipilä, Jussi O. T. ; Kälviäinen, Reetta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ankle</topic><topic>Clinical</topic><topic>clinical neurology</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>epileptic syndromes</topic><topic>Finland - epidemiology</topic><topic>hereditary disorders</topic><topic>Humans</topic><topic>Male</topic><topic>Metabolic disorders</topic><topic>Patients</topic><topic>rare epilepsies</topic><topic>Trauma</topic><topic>Unverricht-Lundborg Syndrome - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sipilä, Jussi O. T.</creatorcontrib><creatorcontrib>Kälviäinen, Reetta</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta neurologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sipilä, Jussi O. T.</au><au>Kälviäinen, Reetta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</atitle><jtitle>Acta neurologica Scandinavica</jtitle><addtitle>Acta Neurol Scand</addtitle><date>2022-11</date><risdate>2022</risdate><volume>146</volume><issue>5</issue><spage>690</spage><epage>693</epage><pages>690-693</pages><issn>0001-6314</issn><eissn>1600-0404</eissn><abstract>Background
Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these.
Aims of the Study
To investigate the frequency of comorbidities in EPM1.
Methods
Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals.
Results
Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population.
Conclusions
Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.</abstract><cop>Denmark</cop><pub>Hindawi Limited</pub><pmid>36097839</pmid><doi>10.1111/ane.13706</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-6314 |
ispartof | Acta neurologica Scandinavica, 2022-11, Vol.146 (5), p.690-693 |
issn | 0001-6314 1600-0404 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9826374 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Ankle Clinical clinical neurology Cohort Studies Comorbidity Diabetes mellitus Diagnosis epileptic syndromes Finland - epidemiology hereditary disorders Humans Male Metabolic disorders Patients rare epilepsies Trauma Unverricht-Lundborg Syndrome - pathology |
title | Comorbidities in patients with Unverricht–Lundborg disease (EPM1) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comorbidities%20in%20patients%20with%20Unverricht%E2%80%93Lundborg%20disease%C2%A0(EPM1)&rft.jtitle=Acta%20neurologica%20Scandinavica&rft.au=Sipil%C3%A4,%20Jussi%20O.%20T.&rft.date=2022-11&rft.volume=146&rft.issue=5&rft.spage=690&rft.epage=693&rft.pages=690-693&rft.issn=0001-6314&rft.eissn=1600-0404&rft_id=info:doi/10.1111/ane.13706&rft_dat=%3Cproquest_pubme%3E2714065179%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2724447088&rft_id=info:pmid/36097839&rfr_iscdi=true |